1 completed, 1 terminated. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow fluorodeoxyglucose F-18: new trials by email Literature Review of fluorodeoxyglucose F-18 trials Research Report on fluorodeoxyglucose F-18
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Computed Tomography, fluorodeoxyglucose F-18, Fluorine F 18 L-glutamate Derivative BAY94-9392 - Lung Carcinoma, Solitary Pulmonary Nodule | Phase 2 | Completed | Vanderbilt-Ingram Cancer Center | 46 | 2015-06-16 | 2022-10-19 |
| FDG-PET in Advanced Melanoma [18F]fluorodeoxyglucose, Molecular assays on biopsied tissue, positron emission tomography - Recurrent Melanoma, Stage IIIA Melanoma | Not applicable | Terminated | Vanderbilt-Ingram Cancer Center | 3 | 2012-05-01 | 2017-04-13 |
Cigarette Smoking (1) · Lung Neoplasms (1) · Melanoma (1) · Solitary Pulmonary Nodule (1)
Vanderbilt-Ingram Cancer Center (2)
United States (2)
Chirayu Shah, MD (1) · Tom Yankeelov, PhD (1)
P30CA068485 (2)